Upstart: Promising Recovery Set Up Despite Potentially Lumpy Q2 2026; Reiterate Buy

Upstart benefits from moderating macro risks, strong loan origination growth, and expanding funding partnerships, with the automated originations at 91% improving margins. The management reiterates strong FY2026/FY2028 guidance, with it underscoring a multi-year, profitable growth cadence despite the mixed FQ1'26 performance metrics. Readers are well advised to temper their expectations entering UPST's FQ2'26 earnings call, attributed to the likely lumpy loan originations during the prior Iran conflict. Otherwise, the stock remains compelling at a P/E of 14.95x and a 3Y PEG ratio of 0.40x against historical levels/peers, despite the recently outsized recovery from the March 2026 bottom. UPST remains a compelling Buy for the contrarian, despite the prolonged macroeconomic normalization, the high short interest at 28.03%, and the potentially lumpy FQ2'26 performance. I previously rated Upstart Holdings, Inc. ( UPST ) as a Buy in April 2026, thanks to the profitable growth prospects as observed in the FY2028 targets. In this article, I shall discuss why UPST remains a